home.social
Sign in Create account

#endometrialcarcinoma — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #endometrialcarcinoma, aggregated by home.social.

  1. TumorBoardTuesday @[email protected] ·

    23/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc

    Thanks for joining!
    👋Claim🆓#CME👉bit.ly/3jCyVFJ
    🛑Before you leave…answer polls👇

    🔴Post Poll1️⃣
    🔴Which I/O +🎯tx combo is FDA approved for treatment of advanced or metastatic #EndometrialCarcinoma?

    #bonumce #onctwitter #gyncsm #gynonc #cme #endometrialcarcinoma
  2. TumorBoardTuesday @[email protected] ·

    23/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc

    Thanks for joining!
    👋Claim🆓#CME👉bit.ly/3jCyVFJ
    🛑Before you leave…answer polls👇

    🔴Post Poll1️⃣
    🔴Which I/O +🎯tx combo is FDA approved for treatment of advanced or metastatic #EndometrialCarcinoma?

    #endometrialcarcinoma #cme #gynonc #gyncsm #onctwitter #bonumce
  3. TumorBoardTuesday @[email protected] ·

    8/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc #EndometrialCancer

    Pivotal trials leading to FDA approval in 2L met MSI-H/dMMR #EndometrialCarcinoma

    🔸Pembro: #KEYNOTE158 (phase 2)
    🔹Dostarlimab: #GARNET (phase 1)

    🔑Efficacy & safety data 📷👇

    #bonumce #onctwitter #gyncsm #gynonc #endometrialcancer #endometrialcarcinoma
  4. TumorBoardTuesday @[email protected] ·

    8/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc #EndometrialCancer

    Pivotal trials leading to FDA approval in 2L met MSI-H/dMMR #EndometrialCarcinoma

    🔸Pembro: #KEYNOTE158 (phase 2)
    🔹Dostarlimab: #GARNET (phase 1)

    🔑Efficacy & safety data 📷👇

    #garnet #keynote158 #endometrialcarcinoma #endometrialcancer #gynonc #gyncsm